BIOFLOW-III All-comers Orsiro Safety and Performance Registry
NCT01553526 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1356
Last updated 2016-08-30
Summary
This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES).
Conditions
- Coronary Artery Disease
- Myocardial Ischemia
Sponsors & Collaborators
-
Biotronik AG
lead INDUSTRY
Principal Investigators
-
Esther Gerteis · Biotronik AG
-
Johannes Waltenberger, Prof. · University Hospital Muenster
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2013-03-31
- Completion
- 2017-06-30
Countries
- Austria
- Chile
- Denmark
- France
- Germany
- Italy
- Latvia
- Netherlands
- Portugal
- Spain
- Sweden
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
BIOFLOW III Asia Registry Orsiro Stent System
NCT01941290 ·Status: COMPLETED
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630 ·Status: RECRUITING ·Phase: NA
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
BIOFLOW-III Israel Satellite Registry
NCT01895712 ·Status: COMPLETED
-
BIOFLOW-III Canada Satellite Registry
NCT01880242 ·Status: COMPLETED
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 ·Status: UNKNOWN ·Phase: NA
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.
NCT01651390 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-china Post-marketing Study (BIOTRONIK)
NCT05667285 ·Status: TERMINATED
-
First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions
NCT01214148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
NCT01556126 ·Status: COMPLETED ·Phase: NA
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent
NCT03263260 ·Status: COMPLETED
-
The Direct III Post Market Study
NCT02693158 ·Status: COMPLETED
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
NCT02508714 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Biodegradable Stents: Orsiro and BioMatrix
NCT02084901 ·Status: COMPLETED ·Phase: PHASE4
-
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT02039739 ·Status: COMPLETED